C12N 2740/11051
Methods of production or purification of viral material
C12N2740/11051 (Methods of production or purification of viral material) appears on 8 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 7
- Assignees
- 9
- Inventors
- 19
- Latest grant
- 21 Jan 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Delivery of packaged RNA to mammalian cells21 Jan 2020US 10,538,743 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Delivery of packaged RNA to mammalian cells29 Nov 2016US 9,506,041 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Spontaneously immortalized avian cell line17 May 2016US 9,340,815 B2The United States of America as represented by the Secretary of Agriculture
- Assay to detect viral uncoating6 Oct 2009US 7,598,072 B2Wisconsin Alumni Research Foundation
- Packaging cells10 Feb 1998US 5,716,832 AChiron Viagene, Inc.
- Dual targeted gene therapy17 Sep 2026US 2026/0275377 A1Kelonia Therapeutics, Inc.
- Glycoproteins for pseudotyping retroviral vector particles25 Dec 2025US 2025/0388924 A1Medizinische Hochschule Hannover
- Delivery of packaged rna to mammalian cells2 Apr 2020US 2020/0102545 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Delivery of packaged rna to mammalian cells24 Nov 2016US 2016/0340653 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Spontaneously immortalized avian cell line26 Mar 2015US 2015/0087022 A1The United States of America as represented by the Secretary of Agriculture
Most cited
By later US patents
- Helper cell261US 4,650,764 AWisconsin Alumni Research Foundation · 1987
- Process for preparing virus disease live vaccines107US 4,071,618 AThe Research Foundation for Microbial Diseases of Osaka University · 1978
- Retroviral packaging cell lines77US 5,591,624 AChiron Viagene, Inc. · 1997
- Packaging cells23US 5,716,832 AChiron Viagene, Inc. · 1998
- Delivery of packaged RNA to mammalian cells6US 10,538,743 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2020